 recently shown cytosolic thyroid hormone binding protein (p58-M2) human epidermoid carcinoma A431 cells monomer pyruvate kinase, subtype M2 (PKM2). characterize molecular properties p58-M2, overexpressed p58-M2 Escherichia coli purified homogeneity. 22 degrees C, monomeric p58-M2, exhibited kinase activity apparent Vmax 22 +/- 9 units/mg. Km adenosine diphosphate (ADP) phosphoenolpyruvate (PEP) 3.85 +/- 2.4 1.55 +/- 0.73 mM, respectively. Upon activation fructose 1,6-bisphosphate (Fru-1,6-P2), Vmax Km ADP PEP changed 490 +/- 27 units/mg 0.63 +/- 0.09 0.13 +/- 0.01 mM, respectively. results indicated p58-M2 intrinsic kinase activity. Analysis molecular size indicated activation p58-M2, Fru-1,6-P2 resulted association monomeric p58-M2 tetrameric PKM2. p58-M2 bound 3,3',5-triiodo-L-thyronine (T3) (Ka = 1.7 x 10(7) M-1) exhibited analogue specificity, whereas PKM2 bind thyroid hormone. order binding affinity L-T3 greater L-thyroxine greater 3,3',5-triiodothyropropionic acid greater 3'-isopropyl-3,5-triiodo-L-thyronine greater 3'5',3-triiodo-L-thyronine. Binding T3 analogues resulted inhibition kinase activity p58-M2. order kinase inhibitory activity preventing association tetrameric PKM2 parallel binding activity.(ABSTRACT TRUNCATED 250 WORDS)